Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2)
Yan Li
Ling Li
Yong De Peng
Guang Yao Song
Shan Dong Ye
Li Ying Du
Jia Ning Hou
Qiu He Ji
10.6084/m9.figshare.8218229.v1
https://adisjournals.figshare.com/articles/figure/Efficacy_and_Safety_of_Dulaglutide_Versus_Insulin_Glargine_in_Chinese_T2DM_Patients_A_Subgroup_Analysis_of_a_Randomized_Trial_AWARD-CHN2_/8218229
<p><strong>Provide enhanced digital features for this article</strong><br></p><p>
If you are an author of this publication and would like to provide additional
enhanced digital features for your article then please contact <u>adisrapidplus@springer.com</u>.<br>
<br>
The journal offers a range of additional features designed to increase
visibility and readership. All features will be thoroughly peer reviewed to
ensure the content is of the highest scientific standard and all features are
marked as ‘peer reviewed’ to ensure readers are aware that the content has been
reviewed to the same level as the articles they are being presented alongside.
Moreover, all sponsorship and disclosure information is included to provide
complete transparency and adherence to good publication practices. This ensures
that however the content is reached the reader has a full understanding of its
origin. No fees are charged for hosting additional open access content.<br>
<br>
Other enhanced features include, but are not limited to:<br>
• Slide decks<br>
• Videos and animations<br>
• Audio abstracts<br>
• Audio slides</p>
2019-06-14 11:49:07
China
Dulaglutide
Glucagon-like peptide-1 receptor agonist
Glycated haemoglobin
Type 2 diabetes mellitus